ClinicalTrials.Veeva

Menu
C

Clinical Site Partners, LLC | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AD109
TAK-994
Verekitug
UPB-101

Parent organization

This site is a part of Clinical Site Partners, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants with Severe Asthma (VALIANT)

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate t...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Active, not recruiting
OSA
Drug: Placebo
Drug: AD109

Trial sponsors

Apnimed logo
Bavarian Nordic logo
Janssen (J&J Innovative Medicine) logo
Takeda logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems